Sarepta Announces FDA Acceptance Of Sndas For Amondys 45® And Vyondys 53®

Sarepta Therapeutics Inc NASDAQ:SRPT:

• SAREPTA ANNOUNCES FDA ACCEPTANCE OF SNDAS FOR AMONDYS 45® AND VYONDYS 53®

• SAREPTA THERAPEUTICS - FDA SETS PDUFA TARGET ACTION DATE OF FEBRUARY 28, 2027